Newsletter

What’s New in Femtech This Week? (Aug 24, 2023)

Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. This Week’s Highlights Visana Health secures $10.1M in seed funding to scale its virtual-first women’s healthcare model. Mercury 13 launches a $100M fund to acquire women’s football clubs. Delphinus raises $12M for…

What’s New in Femtech This Week? (Aug 16, 2023)

Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights Escala Medical secures €5.5M EIC funding to advance pelvic organ prolapse treatment. Sequel‘s Spiral Tampon receives FDA approval as a medical device. Lucina…

What’s New in Femtech This Week? (Aug 10, 2023)

Mirvie receives a $4.6M grant from the Gates Foundation to study preeclampsia in Sub-Saharan Africa. Helpful App raises $7.5M in seed funding to streamline caregiver support. Peterson Center on Healthcare launches a $50M initiative to evaluate digital health innovations. BPEA EQT is to acquire a majority stake in Indira IVF, India’s largest chain of fertility clinics. The FDA approves the first oral treatment for postpartum depression. New research assesses mobile apps providing abortion information. This week’s newsletter is powered by…

What’s New in Femtech This Week? (Aug 3, 2023)

Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights HerMD adds $18M to expand its women’s health clinic network. Béa Fertility secures £2.5M to launch its at-home fertility treatment in the UK. Pelvital raises $2.68M for Flyte, its FDA-cleared treatment…

What’s New in Femtech This Week? (July 27, 2023)

Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. This Week’s Highlights Kasha adds $21M in Series B funding to scale its women’s health platform in Africa. Family First secures $11M in Series A funding for its caregiver…

What’s New in Femtech This Week? (July 20, 2023)

Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. This Week’s Highlights Herself Health raises $26M in Series A funding to reinvent healthcare for women 65+. Incontinence care company Attn: Grace adds $2M to invest in growth. Waverly Diagnostics adds $1.35M to…

What’s New in Femtech This Week? (July 13, 2023)

Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights Infant formula company Bobbie raises $70M in Series C funding and acquires Nature’s One. Sonio raises $14M in Series A funding for its AI-based prenatal screening and diagnostics platform. Belgium-based…

What’s New in Femtech This Week? (July 6, 2023)

This Week’s Highlights UK-based fertility benefits startup Fertifa adds £5M in seed funding; Alfie Health launches its AI-based ObesityRx platform after raising $2.1M. Kindred raises $1M in seed funding to scale its hybrid women’s healthcare model in the Philippines. Mark Cuban Cost Plus Drug Company Teams Up with Male Fertility Company Posterity Health. FDA approves Thermo Fisher‘s Immunoassays for Risk Assessment of Preeclampsia. Infant formula company Bobbie and breast pump maker Elvie launch new retail experience to normalize combo feeding. INVO…